mdlinx mdlinx

Family Medicine - Pain Management News & Articles

MDLinx Family Medicine stands out from other primary care literature review services because of our dedication to keeping our members current in less time. On a daily basis, receive an email with just the ‘headlines’ covering everything important that published in your specialty in the past 24 hours. Or, choose to Focus On the top articles published in the hottest topics in primary care, such as heart failure, depression, diabetes mellitus, eczema/psoriasis, infectious diseases, rheumatoid arthritis, COPD, and many more.

Additional bonus content is also available on this page, including clinical pearls from The Smartest Family Physician, a daily quiz competition from the editors of MDLinx Internal Medicine in collaboration with the Cleveland Clinic Center for Continuing Education. Additionally, enjoy the can’t-miss articles highlighted by our own physician editor, D. Scott Cunningham, MD, PhD.

Your Unread Messages in Family Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx
New! >> Find out who is the Smartest Doc in Family Medicine!

Articles

Latest (7) Full Text Articles (157) Focus on Thyroid Disease
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

561 The cerebral venous system and anatomical predisposition to high altitude headache Annals of Neurology , November 20, 2012

562 Cortisol Response to Experimental Pain in Patients with Chronic Low Back Pain and Patients with Major Depression Pain Medicine, November 16, 2012    Clinical Article

563 Migraine is not associated with enhanced atherosclerosis Cephalalgia, November 16, 2012    Clinical Article

564 Fibromyalgia Syndrome: Etiology, Pathogenesis, Diagnosis, and Treatment Full Text Pain Research and Treatment, November 16, 2012

565 Is alcohol intake associated with low back pain? A systematic review of observational studies Manual Therapy , November 16, 2012    Evidence Based Medicine

566 Prediction of Morphine Clearance in the Paediatric Population How Accurate are the Available Pharmacokinetic Models Clinical Pharmacokinetics, November 16, 2012

567 Overuse of paracetamol caffeine aspirin powders affects cerebral glucose metabolism in chronic migraine patients European Journal of Neurology, November 15, 2012    Clinical Article

568 High frequency of inflammatory back pain and other features of spondyloarthritis in patients with rheumatoid arthritis Rheumatology International, November 15, 2012

569 The effect of dry needling in the treatment of myofascial pain syndrome: a randomized double-blinded placebo-controlled trial Clinical Rheumatology, November 15, 2012    Clinical Article

570 Frequency and Burden of Headache-Related Nausea: Results From the American Migraine Prevalence and Prevention (AMPP) Study Headache: The Journal of Head and Face Pain, November 14, 2012    Clinical Article

571 An Open-Label Trial of a Sumatriptan Auto-Injector for Migraine in Patients Currently Treated With Subcutaneous Sumatriptan Headache: The Journal of Head and Face Pain, November 14, 2012    Clinical Article

572 Low back pain-related beliefs and likely practice behaviours among final-year cross-discipline health students European Journal of Pain, November 14, 2012

573 Genetic and environmental influences on non-specific neck pain in early adolescence: A classical twin study European Journal of Pain, November 14, 2012

574 Improving services for back pain: putting the patient at the centre of interprofessional education Quality in Primary Care, November 13, 2012

575 Oxygen treatment is effective in migraine with autonomic symptoms Cephalalgia, November 13, 2012

576 Migraine and Psychiatric Comorbidities Among Sub-Saharan African Adults Headache: The Journal of Head and Face Pain, November 13, 2012

577 Headache Direction and Aura Predict Migraine Responsiveness to Rimabotulinumtoxin B Headache: The Journal of Head and Face Pain, November 13, 2012

578 Sensory innervation and inflammatory cytokines in hypertrophic synovia associated with pain transmission in osteoarthritis of the hip: a case-control study Rheumatology, November 13, 2012

579 NGX426, an Oral AMPA-Kainate Antagonist, Is Effective in Human Capsaicin-Induced Pain and Hyperalgesia Pain Medicine, November 13, 2012

580 Cerebral Stimulation for the Affective Component of Neuropathic Pain Neuromodulation: Technology at the Neural Interface, November 13, 2012

50 available pages First Previous 29 30 31 32 33 34 35 36 37 38 Next Last

Clinical Pearls in Family Medicine

Highlights in Family Medicine

Vitamin D supplementation decreases systemic inflammation in T2DM

In a 12-week randomized, controlled trial, ingestion of a vitamin D-fortified yogurt (170 mg calcium + 500 IU vitamin D/250 mL; n=50) twice daily decreased markers of inflammation compared with placebo yogurt (170 mg calcium; n=50). Compared with baseline measures, the 25(OH)D levels were increased and the TNF-alpha, IL-6, hsCRP, SAA, and IL-10 levels were decreased in the group supplemented with vitamin D compared with the group that received placebo.

Read the article summary

Mediterranean diet associated with decreased diabetes, cardiovascular events, and all-cause mortality

Researchers at the University of Palermo conducted a study involving 9109 subjects with a mean follow-up of 6.2 years which showed that the subjects who adhered to a Mediterranean diet had increased dietary fiber, decreased total dietary fat, and an increased intake of monosaturated-to-saturated fats. Further, the incidence of diabetes, cardiovascular events, and all-cause mortality was lower in the subjects who followed a Mediterranean diet.

Read the article summary

Natalizumab superior to IFN-? 1a in MS patients

Based on a retrospective study conducted at the Federico II University (Naples), researchers have concluded that treatment of patients (n=84) with relapsing-remitting MS natalizumab for 12-24 months resulted in a greater reduction in disease activity (annualized relapse rate, .24 vs. .55, respectively) and disability progression than patients treated with INF-? 1a. The number of contrast-enhancing lesions was also less in the natalizumab-treated group.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Other Topics in Family Medicine

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close